<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">In September 2012, initial reports of infection with another novel human coronavirus began in Saudi Arabia, with rapid spread to neighboring Egypt, Iran, Jordan, Kuwait, Lebanon, Qatar, Oman, Yemen, and the United Arab Emirates, then to other continents with airline travel [
 <xref ref-type="bibr" rid="CR35">35</xref>]. Middle East Respiratory Syndrome Coronavirus (MERS CoV) has been reported to cause severe respiratory tract infection in adult patients, with a mortality rate as high as 60%, most commonly in those with diabetes mellitus and end stage renal disease [
 <xref ref-type="bibr" rid="CR36">36</xref>]. After a median incubation period of 5 days (range, 2â€“14 days), patients often present with fever, cough, dyspnea, and diarrhea after close contact with an infected case and/or travel from an area where infection is active. Coryza, headache, nausea, vomiting, and abdominal pain have also been reported [
 <xref ref-type="bibr" rid="CR37">37</xref>]. Laboratory findings include thrombocytopenia, leukopenia, lymphopenia, and elevated transaminases and LDH. Coinfection with other respiratory viruses has been reported [
 <xref ref-type="bibr" rid="CR38">38</xref>]. As with SARS-CoV, health care workers are at risk for infection [
 <xref ref-type="bibr" rid="CR39">39</xref>, 
 <xref ref-type="bibr" rid="CR40">40</xref>]. Dromedary camels have been reported to harbor infection in the Arabian Peninsula, although the mode of transmission of infection has not yet been elucidated [
 <xref ref-type="bibr" rid="CR41">41</xref>].
</p>
